ALBERTDAVDPharmaceuticals
Albert David Ltd — PE Ratio & Valuation Analysis
₹587.05
-6.71%
Current P/EN/AxPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E14.8x100.0% below avg
✅
100.0% Discount to Industry
ALBERTDAVD P/E N/Ax vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹30.14 | ₹737 | 24.4x |
| 2024 | ₹132.15 | ₹1327 | 10x |
| 2023 | ₹63.39 | ₹975 | 15.4x |
| 2022 | ₹61.78 | ₹567 | 9.2x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Albert David Ltd Valuation
Albert David Ltd (ALBERTDAVD) currently trades at N/Ax earnings. The Pharmaceuticals sector average PE is 31.77x. Historically, ALBERTDAVD has traded at an average PE of 14.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
4.39%
Dividend Yield
0.64%
More on Albert David Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.